Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

During the Trading Day
4.02 -0.03 / -0.74%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.02 -0.0008 / -0.02%
 
Volume: 131.00
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Henney Christopher S
Director
Buy1/30/201725,324$4.11$104.1K-3.34%
Love Ted W
Director
Buy2/02/201723,000$4.24$97.5K-6.25%
Myers Scott D /oncothyreon/
President & Chief Executive Officer
Buy1/27/201720,500$3.76$77.1K+5.47%
Myers Scott D /oncothyreon/
President & Chief Executive Officer
Buy5/12/20172,800$4.00$11.2K-3.11%
Fyfe Gwen A
Director
Sale6/24/20172,265$3.78$8.6K+2.02%
Henney Christopher S
Director
Sale6/24/20172,265$3.78$8.6K+2.02%
James Steven P
Director
Sale6/24/20172,265$3.78$8.6K+2.02%
Love Ted W
Director
Sale6/24/20172,265$3.78$8.6K+2.02%
Spiegelman Daniel K
Director
Sale6/24/20172,265$3.78$8.6K+2.02%
Myers Scott D /oncothyreon/
President & Chief Executive Officer
Buy3/31/20172,000$4.11$8.2K-2.17%
Page of 3